Links between PEAK1 expression and the clinicopathological characteristics in PTC patients were determined (Table 1) Positive PEAK1 expression was associated with TNM stage, lymph node metastasis, extrathyroidal Invasion and high ATA risk, but not related with persistence/recurrence. Here, PEAK1 is linked to metastasis.